Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estrogen in the Prevention of Atherosclerosis Trial
NCT00115024Phase 3Completed
- Sponsor
- National Institute on Aging
- Start
- Apr 1994
- Primary completion
- Nov 1998
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in atherosclerosis comparing Estrace with Placebo (2 arms). Primary endpoint: Rate of change of distal common carotid artery far wall intima-media thickness at 2 years. Started Apr 1994; status: completed.
02
Drugs
estradiol
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT00115024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00115024.